Vertex Announces Collaboration With Janssen to Initiate Phase 2 All-Oral Study …

Vertex Announces Collaboration with Janssen To Initiate Phase 2 All-Oral Study …

Filed under: drug addiction treatment act of 2000

As part of the collaboration, Janssen will conduct a drug-drug interaction study with VX-135 and simeprevir to support the planned initiation of a Phase 2 proof-of-concept study in early 2013, pending discussions with regulatory authorities. … "This …
Read more on DailyFinance

Nymox to Present at 7th Annual Singular Research Conference

Filed under: drug addiction treatment act of 2000

The Company's lead drug candidate, NX-1207, is currently in late stage Phase 3 clinical trial development in the U.S. for the treatment of benign prostatic hyperplasia (BPH), a common condition of older men associated with growth in prostate size as …
Read more on NASDAQ

Geron Corporation Reports 2012 Third Quarter Financial Results and Events

Filed under: drug addiction treatment act of 2000

She co-founded Proteolix, Inc. and was responsible for leading the development of Proteolix's second generation proteasome inhibitor, carfilzomib (now marketed as Kyprolis), for the treatment of multiple myeloma, from discovery through completion of …
Read more on Reuters